Identification and Synthesis of Selected In Vitro Generated Metabolites of the Novel Selective Androgen Receptor Modulator (SARM) 2f
Molecules · 2023
DOI: 10.3390/molecules28145541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Tristan Möller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933 Cologne, Germany. Hauptthemen laut MEDLINE: Receptors, Androgen, Anabolic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Ministry of the Interior and Community of the Federal Republic of Germany.
Abstract (Originalsprache)
Among anabolic agents, selective androgen receptor modulators (SARMs) represent a new class of potential drugs that can exhibit anabolic effects on muscle and bone with reduced side effects due to a tissue-selective mode of action. Besides possible medical applications, SARMs are used as performance-enhancing agents in sports. Therefore, they are prohibited by the World Anti-Doping Agency (WADA) in and out of competition. Since their inclusion into the WADA Prohibited List in 2008, there has been an increase in not only the number of adverse analytical findings, but also the total number of SARMs, making continuous research into SARMs an ongoing topic in the field of doping controls. 4-((2R,3R)-2-Ethyl-3-hydroxy-5-oxopyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile (SARM 2f) is a novel SARM candidate and is therefore of particular interest for sports drug testing. This study describes the synthesis of SARM 2f using a multi-step approach, followed by full characterization using liquid chromatography–high-resolution mass spectrometry (LC-HRMS) and nuclear magnetic resonance spectroscopy (NMR). To provide the first insights into its biotransformation in humans, SARM 2f was metabolized using human liver microsomes and the microsomal S9 fraction. A total of seven metabolites, including phase I and phase II metabolites, were found, of which three metabolites were chemically synthesized in order to confirm their structure. Those can be employed in testing procedures for routine doping controls, further improving anti-doping efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933 Cologne, Germany.
- Faculty of Chemistry, University of Cologne, Greinstraße 4-6, 50939 Cologne, Germany.
- European Monitoring Center for Emerging Doping Agents (EuMoCEDA), 50933 Cologne, Germany.
Förderung
- Federal Ministry of the Interior and Community of the Federal Republic of Germany
Zitieren
APA
Möller, T., Wen, H. C., Naumann, N., Krug, O., & Thevis, M. (2023). Identification and Synthesis of Selected In Vitro Generated Metabolites of the Novel Selective Androgen Receptor Modulator (SARM) 2f. Molecules. https://doi.org/10.3390/molecules28145541
Vancouver
Möller T, Wen HC, Naumann N, Krug O, Thevis M. Identification and Synthesis of Selected In Vitro Generated Metabolites of the Novel Selective Androgen Receptor Modulator (SARM) 2f. Molecules. 2023. doi:10.3390/molecules28145541
BibTeX
@article{Mller2023,
author = {Möller, Tristan and Wen, Hui-Chung and Naumann, Nana and Krug, Oliver and Thevis, Mario},
title = {Identification and Synthesis of Selected In Vitro Generated Metabolites of the Novel Selective Androgen Receptor Modulator (SARM) 2f},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28145541}
}
EUVIMED